6:10 PM
 | 
Sep 12, 2012
 |  BC Extra  |  Company News

FDA to review once-monthly aripiprazole

Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) and partner H. Lundbeck A/S (CSE:LUN) said FDA accepted for review a resubmitted NDA for a once-monthly depot formulation of aripiprazole for the...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >